Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2016, Article ID 9694372, 6 pages
http://dx.doi.org/10.1155/2016/9694372
Research Article

Increased Prevalence of Mutant Allele Pfdhps 437G and Pfdhfr Triple Mutation in Plasmodium falciparum Isolates from a Rural Area of Gabon, Three Years after the Change of Malaria Treatment Policy

Department of Parasitology-Mycology and Tropical Medicine, Faculty of Medicine, Université des Sciences de la Santé, BP 4009, Libreville, Gabon

Received 23 October 2015; Revised 22 January 2016; Accepted 16 February 2016

Academic Editor: Donatella Taramelli

Copyright © 2016 Jacques-Mari Ndong Ngomo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Roper, R. Pearce, B. Bredenkamp et al., “Antifolate antimalarial resistance in southeast Africa: a population-based analysis,” The Lancet, vol. 361, no. 9364, pp. 1174–1181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Roper, R. Pearce, S. Nair, B. Sharp, F. Nosten, and T. Anderson, “Intercontinental spread of pyrimethamine-resistant malaria,” Science, vol. 305, no. 5687, p. 1124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Wongsrichanalai, A. L. Pickard, W. H. Wernsdorfer, and S. R. Meshnick, “Epidemiology of drug-resistant malaria,” The Lancet Infectious Diseases, vol. 2, no. 4, pp. 209–218, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. World Malaria Report 2011, http://www.who.int/malaria/world_malaria_report_2011/en/index.html.
  5. WHO: World Health Organization, A Strategic Framework for Malaria Prevention and Control during Pregnancy in the African Region, AFR/MAL/04/01, WHO Regional Office for Africa, Brazzaville, Congo, 2004.
  6. D. J. Bzik, W.-B. Li, T. Horii, and J. Inselburg, “Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 23, pp. 8360–8364, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. D. R. Brooks, P. Wang, M. Read, W. M. Watkins, P. F. Sims, and J. E. Hyde, “Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine,” European Journal of Biochemistry, vol. 224, no. 2, pp. 397–405, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. A. F. Cowman, M. J. Morry, B. A. Biggs, G. A. M. Cross, and S. J. Foote, “Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 23, pp. 9109–9113, 1988. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Sridaran, S. K. McClintock, L. M. Syphard, K. M. Herman, J. W. Barnwell, and V. Udhayakumar, “Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations,” Malaria Journal, vol. 9, no. 1, article 247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. W. H. Wernsdorfer and H. Noedl, “Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology,” Current Opinion in Infectious Diseases, vol. 16, no. 6, pp. 553–558, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Picot, P. Olliaro, F. De Monbrison, A.-L. Bienvenu, R. N. Price, and P. Ringwald, “A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria,” Malaria Journal, vol. 8, article 89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Costanzo and D. L. Hartl, “The evolutionary landscape of antifolate resistance in Plasmodium falciparum,” Journal of Genetics, vol. 90, no. 2, pp. 187–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. T. Bousema, L. C. Gouagna, A. M. Meutstege et al., “Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya,” Tropical Medicine and International Health, vol. 8, no. 5, pp. 427–430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. K. Bouyou-Akotet, D. P. Mawili-Mboumba, and M. Kombila, “Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon,” BMC Pregnancy and Childbirth, vol. 13, article 52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D.-P. Mawili-Mboumba, M.-T. Ekala, F. Lekoulou, and F. Ntoumi, “Molecular analysis of DHFR and DHPS genes in P. falciparum clinical isolates from the Haut-Ogooué region in Gabon,” Acta Tropica, vol. 78, no. 3, pp. 231–240, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Aubouy, S. Jafari, V. Huart et al., “DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy,” Journal of Antimicrobial Chemotherapy, vol. 52, no. 1, pp. 43–49, 2003. View at Publisher · View at Google Scholar
  17. D. P. Mawili-Mboumba, M. K. B. Akotet, E. Kendjo et al., “Increase in malaria prevalence and age of at risk population in different areas of Gabon,” Malaria Journal, vol. 12, no. 1, article 3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. P. Mawili-Mboumba, J. M. N. Ngomo, F. Maboko et al., “Pfcrt 76T and pfmdr1 86Y allele frequency in plasmodium falciparum isolates and use of self-medication in a rural area of Gabon,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 108, no. 11, Article ID tru147, pp. 729–734, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Nsimba, V. Guiyedi, M. Mabika-Mamfoumbi et al., “Sulfadoxine-pyrimethamine versus amodiquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide the national policy,” Malaria Journal, vol. 7, article 31, 2008. View at Google Scholar
  20. T. Planche, S. Krishna, M. Kombila et al., “Comparison of methods for the rapid laboratory assessment of children with malaria,” The American Journal of Tropical Medicine and Hygiene, vol. 65, no. 5, pp. 599–602, 2001. View at Google Scholar · View at Scopus
  21. M. T. Duraisingh, J. Curtis, and D. C. Warhurst, “Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropferoate synthetase genes by PCR and restriction digestion,” Experimental Parasitology, vol. 89, no. 1, pp. 1–8, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Mombo-Ngoma, S. Oyakhirome, R. Ord et al., “High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children,” Malaria Journal, vol. 10, article 123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. K. Bouyou-Akotet, D. P. Mawili-Mboumba, T. de Dieu Tchantchou, and M. Kombila, “High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 3, pp. 438–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Mwai, E. Ochong, A. Abdirahman et al., “Chloroquine resistance before and after its withdrawal in Kenya,” Malaria Journal, vol. 8, article 106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Afsharpad, S. Zakeri, S. Pirahmadi, and N. D. Djadid, “Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran,” Acta Tropica, vol. 121, no. 1, pp. 13–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Ndiaye, B. Dieye, Y. D. Ndiaye et al., “Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in thies, senegal,” International Journal for Parasitology: Drugs and Drug Resistance, vol. 3, pp. 135–142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Koukouikila-Koussounda, D. Bakoua, A. Fesser, M. Nkombo, C. Vouvoungui, and F. Ntoumi, “High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo,” Infection, Genetics and Evolution, vol. 33, pp. 32–36, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Ogouyèmi-Hounto, N. T. Ndam, D. K. Gazard et al., “Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy,” Malaria Journal, vol. 12, article 147, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. J. P. Wendler, J. Okombo, R. Amato et al., “A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya,” PLoS ONE, vol. 9, no. 5, Article ID e96486, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Geiger, G. Compaore, B. Coulibaly et al., “Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina Faso,” Tropical Medicine and International Health, vol. 19, no. 6, pp. 690–697, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. K. Bouyou-Akotet, M.-L. Tshibola, D. P. Mawili-Mboumba et al., “Frequencies of dhfr/dhps multiple mutations and Plasmodium falciparum submicroscopic gametocyte carriage in Gabonese pregnant women following IPTp-SP implementation,” Acta Parasitologica, vol. 60, no. 2, pp. 218–225, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Nzila, E. K. Mberu, J. Sulo et al., “Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 4, pp. 991–996, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. J. G. Kublin, F. K. Dzinjalamala, D. D. Kamwendo et al., “Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria,” Journal of Infectious Diseases, vol. 185, no. 3, pp. 380–388, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. R. A. Mubjer, A. A. Adeel, M. L. Chance, and A. A. Hassan, “Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications,” Malaria Journal, vol. 10, article 245, 2011. View at Publisher · View at Google Scholar · View at Scopus